Sponsored Links
| NCCN Updates NHL Guidelines To Incorporate FDA Approvals Of New Treatment Options |
 |
 |
 |
| Medical News - Lymphoma and Leukemia | |||
|
Two recent FDA approvals have prompted the National Comprehensive Cancer Network (NCCN) to update the NCCN Clinical Practice Guidelines in Oncology(TM) for Non-Hodgkin's Lymphomas to include ofatumumab (Azerra(TM), GlaxoSmithKline) and romidepsin (Istodax(R), Gloucester Pharmaceuticals) as treatment options for select patients with two types of Non-Hodgkin's Lymphomas... Read more: Lymphoma / Leukemia / Myeloma News From Medical News Today
|